Sg3 Management, LLC Zymeworks Inc. Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$6.0 - $16.98 $225,000 - $636,750
-37,500 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$15.19 - $29.33 $372,155 - $718,585
24,500 Added 188.46%
37,500 $615,000
Q3 2021

Nov 15, 2021
BUY
$27.35 - $37.28 $355,550 - $484,640
13,000 New
13,000 $378,000
Q4 2020

Feb 16, 2021
SELL
$39.12 - $54.99 $7.04 Million - $9.9 Million
-180,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$29.21 - $46.58 $5.26 Million - $8.38 Million
180,000 New
180,000 $8.38 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $869M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email